BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18084318)

  • 1. Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29).
    Gallicchio M; Rosa AC; Dianzani C; Brucato L; Benetti E; Collino M; Fantozzi R
    Br J Pharmacol; 2008 Mar; 153(5):870-8. PubMed ID: 18084318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.
    Dianzani C; Brucato L; Gallicchio M; Rosa AC; Collino M; Fantozzi R
    Br J Pharmacol; 2008 Mar; 153(6):1153-61. PubMed ID: 18084316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
    Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
    J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells.
    Lin WN; Luo SF; Lee CW; Wang CC; Wang JS; Yang CM
    Cell Signal; 2007 Jun; 19(6):1258-67. PubMed ID: 17303384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate mediates ICAM-1-dependent monocyte adhesion through p38 MAPK and p42/p44 MAPK-dependent Akt activation.
    Lin CC; Lee IT; Hsu CH; Hsu CK; Chi PL; Hsiao LD; Yang CM
    PLoS One; 2015; 10(3):e0118473. PubMed ID: 25734900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells.
    Yilmaz Ç; Köksoy S; Çeker T; Aslan M
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2259-2272. PubMed ID: 34436652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphoraphane inhibited the expressions of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 through MyD88-dependent toll-like receptor-4 pathway in cultured endothelial cells.
    Shan Y; Lin N; Yang X; Tan J; Zhao R; Dong S; Wang S
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):215-22. PubMed ID: 20880684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways.
    Chae YJ; Kim CH; Ha TS; Hescheler J; Ahn HY; Sachinidis A
    Cell Physiol Biochem; 2007; 20(6):859-66. PubMed ID: 17982268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
    Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
    Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells.
    Zhou Z; Connell MC; MacEwan DJ
    Cell Signal; 2007 Jun; 19(6):1238-48. PubMed ID: 17292586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of p42/p44 MAPK, JNK, and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells.
    Lin FS; Lin CC; Chien CS; Luo SF; Yang CM
    J Cell Physiol; 2005 Feb; 202(2):464-73. PubMed ID: 15389584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.
    Ho AW; Wong CK; Lam CW
    Immunobiology; 2008; 213(7):533-44. PubMed ID: 18656701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation.
    Steffel J; Hermann M; Greutert H; Gay S; Lüscher TF; Ruschitzka F; Tanner FC
    Circulation; 2005 Apr; 111(13):1685-9. PubMed ID: 15795326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2.
    Hsu AL; Ching TT; Wang DS; Song X; Rangnekar VM; Chen CS
    J Biol Chem; 2000 Apr; 275(15):11397-403. PubMed ID: 10753955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts.
    Luo SF; Fang RY; Hsieh HL; Chi PL; Lin CC; Hsiao LD; Wu CC; Wang JS; Yang CM
    Arthritis Rheum; 2010 Jan; 62(1):105-16. PubMed ID: 20039412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin inhibits monocyte adhesion to HUVECs through the NF-κB and MAPK pathways in vitro.
    Wang Y; Cao J; Fan Y; Xie Y; Xu Z; Yin Z; Gao L; Wang C
    Int J Mol Med; 2016 Jun; 37(6):1567-75. PubMed ID: 27122190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
    Xiao H; Zhang Q; Lin Y; Reddy BS; Yang CS
    Int J Cancer; 2008 May; 122(9):2115-24. PubMed ID: 18172863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism.
    Chen L; Zhao Q; Wang XL; You R; Zhang YH; Ji H; Lai YS
    Vascul Pharmacol; 2011; 55(5-6):135-42. PubMed ID: 21777697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.